Back to search

Sweden· SE-20160109000029

Maxalt 5 mg Tablett

A medicinal product containing rizatriptan benzoate, registered in Sweden by Ebb Medical AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedMaxalt 5 mg TablettATC—REGISTER NO.SE-20160109000029PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Rizatriptan Benzoate
Manufacturer
Ebb Medical AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20160109000029

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rizatriptan benzoate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rizatriptan benzoate products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Maxalt, Maxalt Rapitab
  • Belgium · Maxalt, Maxalt Lyo
  • Germany · Maxalt, Maxalt Lingua
  • Denmark · Maxalt Smelt, Rizatripan
  • Spain · Maxalt, Maxalt Max
  • Finland · Maxalt, Maxalt Rapitab
  • France · Maxalt, Maxaltlyo
  • United Kingdom (Northern Ireland) · Maxalt, Maxalt Melt
  • Greece · Flixan, Maxalt
  • Croatia · Maxalt Rpd
  • Hungary · Calvinia
  • Ireland · Rizadia
  • Iceland · Maxalt Smelt, Rizatriptan Alvogen
  • Italy · Emirizia, Maxalt
  • Lithuania · Maxalt
  • Luxembourg · Maxalt Lyo
  • Latvia · Calvinia
  • Malta · Rizatriptan Aurobindo Pharma (Malta)
  • Netherlands · Maxalt, Maxalt Smelt
  • Norway · Maxalt, Maxalt Rapitab
  • Poland · Migrenofen
  • Portugal · Maxalt, Rizatriptano Zim
  • Romania · Maxalt
  • Slovakia · Maxalt Rpd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa9c1f6a-80a4-479e-9bbd-de4ededb18ee
GET /v1/drugs/aa9c1f6a-80a4-479e-9bbd-de4ededb18ee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20160109000029",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20160109000029",
  "product_doc_link": "https://docetp.mpa.se/LMF/Maxalt%205%20mg%20tablet%20DE%20PL_09001bee845b787e.pdf"
}

See everything about rizatriptan benzoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.